Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 29, 2026
- Closes
- Mar 16, 2027 (in 230 days)
Similar opportunities open now
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)OpenNational Institutes of HealthCloses May 2027
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)OpenNational Institutes of HealthCloses Aug 2028Up to $3M
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027Up to $1.5M
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Dec 2027
Classification and identifiers
- Solicitation number
- PAR-24-329
- Assistance listing (CFDA)
- 93.279
Amount
Amount not published by the funder
Who can apply
Private colleges and universities and Small businesses can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.
Related opportunities
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)National Institutes of HealthCloses May 2027
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)National Institutes of HealthCloses Aug 2028Up to $3M
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $1.5M
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Dec 2027
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)National Institutes of HealthCloses Oct 2027